FDA Drug Recalls

Recalls / Class III

Class IIID-0386-2022

Product

Leader, 12HR Allergy & Congestion Relief, Fexofenadine HCl, 60mg Pseudoephedrine HCl 120mg Antihistamine Nasal Decongestant, 20 Extended Release Tablets per box, NDC 70000-0518-1, Distributed by Cardinal Health, Dublin, Ohio 43077, Made in India.

Affected lot / code info
Lot #s: 79C002625B, Exp. 4/30/2022; AC2103328G, Exp. 1/31/2023; AC2106452C, Exp. 3/31/2023.

Why it was recalled

Failed Dissolution Specifications

Recalling firm

Firm
Dr. Reddy's Laboratories, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
107 College Rd E, N/A, Princeton, New Jersey 08540-6623

Distribution

Quantity
10,536 boxes
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2022-01-04
FDA classified
2022-01-18
Posted by FDA
2022-01-26
Terminated
2023-10-20
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0386-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.